Vitamin K Antagonist Anticoagulant
Pregnancy: Contraindicated in pregnancy (teratogenic, fetotoxic)
Warfarin
Brand names: Coumadin, Marevan
Adult dose
Dose: Individualised; typical maintenance 3-9 mg/day
Route: Oral
Frequency: Once daily (same time each day)
Max: Dose adjusted to achieve target INR
Target INR: 2.0-3.0 (AF, DVT/PE, mechanical heart valves require higher target)
Paediatric dose
Dose: Seek specialist opinion N/A/kg
Route: Oral
Frequency: Seek specialist opinion
Max: Seek specialist opinion
Seek specialist opinion
Dose adjustments
Renal
Dose adjustment not required for renal function alone, but bleeding risk increases in renal impairment
Hepatic
Avoid in severe hepatic impairment — impaired clotting factor synthesis makes INR unreliable
Paediatric weight-based calculator
Seek specialist opinion
Clinical pearls
- In elderly with AF, DOACs (apixaban, rivaroxaban, edoxaban) are now preferred over warfarin per NICE NG196 and ESC 2020 — lower intracranial haemorrhage risk and no INR monitoring required
- Warfarin still preferred in: mechanical heart valves, antiphospholipid syndrome with arterial events, or cost/access constraints
- HAS-BLED score: use to identify modifiable bleeding risk factors (hypertension, labile INR, alcohol, NSAIDs) rather than to withhold anticoagulation
- Antidote: Vitamin K (slow reversal); Beriplex/Octaplex (PCC — rapid reversal for major bleeding or emergency surgery)
- MHRA 2014: Warfarin-cranberry juice interaction confirmed — advise patients to avoid
Contraindications
- Active bleeding
- Severe hepatic impairment
- Pregnancy (teratogenic — especially weeks 6-12)
- Thrombocytopenia
Side effects
- Bleeding (the primary risk)
- Skin necrosis (rare — protein C deficiency)
- Purple toe syndrome
- Alopecia
- Osteoporosis (long-term)
Interactions
- Extensive interactions — antibiotics (altered gut flora), NSAIDs, antifungals, amiodarone, SSRIs, statins, herbal medicines (St John's Wort reduces effect)
- Always check interactions before prescribing any new drug in warfarin patients
Monitoring
- INR (weekly initially; then every 4-12 weeks when stable)
- Signs of bleeding
- Blood pressure
Reference: BNFc; BNF 90; NICE NG196 (AF); ESC AF Guidelines 2020; BNF Interactions Appendix. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Warfarin Dose Adjustment Calculator · Anticoagulation
- HAS-BLED Score · Bleeding Risk
- CHADS₂ Score for AF Stroke Risk · Stroke Risk
- HEMORR₂HAGES Bleeding Risk Score · Prognosis
- ATRIA Bleeding Risk Score · Anticoagulation
- DOAC Score for Selecting Direct Oral Anticoagulant in Non-Valvular AF · Anticoagulation
Pathways
- Falls Assessment in Older Adults · NICE CG161 2013
- Delirium Outside ICU · NICE CG103
- Comprehensive Geriatric Assessment (CGA) · BGS / NICE
- Delirium Assessment and Management · NICE CG103 2010
- Frailty Recognition and Management · BGS Frailty Framework / NHS NHSE
- Polypharmacy and Medicines Optimisation · STOPP/START v2 2014 / NICE NG5